|
|
Stock symbol lookup - ARNAHere is some more information available about DOV stock. About the past performance, graphs and links to more detailed analysis. Note that if the markets are closed, the information below can be incorrect.
|


You need to be logged in in order to see and post comments. Not registered yet? Register here
|
Company news
Curaxis completes reverse merger with Auto Search Cars Curaxis completes reverse merger with Auto Search CarsNews-Medical.netPatrick S. Smith, CEO and President of Curaxis, said, "We feel that the Merger allows us to enter the public arena, and ideally positions us to move our ...and more » - G News
OmniComm Systems, Inc. Announces 2010 First Half Results OmniComm Systems, Inc. Announces 2010 First Half ResultsMelodika.net (press release)"We believe that we have positioned ourselves to capitalize on growth throughout the clinical trials arena through our diversification efforts. ...and more &raqu - G News
Nitin Noriah's oration: "India and the Globalization of Business" Nitin Noriah's oration: "India and the Globalization of Business"India Infoline.comLet's take an industry that I know quite well: pharmaceuticals. Pfizer, which was at one point considered the most promising of the pharmaceutical compani - G News
Regulatory watch: Impact of PDUFA on regulatory decision Nature.com-makingNature.comAmong the drugs involved are lorcaserin (developed by Arena Pharmaceuticals) for the treatment of obesity, sodium oxybate (developed by Jazz ... - G News
Arena Pharmaceuticals Climbed To A New High For The Year Arena Pharmaceuticals Climbed To A New High For The YearRTT News(RTTNews) - Arena Pharmaceuticals (ARNA: News ) gapped up slightly Thursday and climbed for the majority of the afternoon. The stock ended the day higher by ...and more » - G News
WATCH FOR ARENA PHARMACEUTICALS TO PULLBACK AFTER GAINING 10.44% YESTERDAY (ARNA) WATCH FOR ARENA PHARMACEUTICALS TO PULLBACK AFTER GAINING 10.44% YESTERDAY (ARNA)Zacks.comJul 30, 2010 (SmarTrend(R) News Watch via COMTEX) -- Arena Pharmaceuticals (NASDAQ:ARNA) traded in a range yesterday that spanned from a low of $6.38 to a ...and mor - G News
Axion BioSystems nabs $2.1M of $2.5M mixed offering TechJournal SouthAxion BioSystems nabs $2.1M of $2.5M mixed offeringTechJournal SouthWhile current development is focused on pharmaceutical drug screening, ongoing development will result in devices in the medical arena. ... - G News
Little heart risk seen with new diet pill Little heart risk seen with new diet pillBeloit Daily NewsArena Pharmaceuticals' lorcaserin is one of three drugs that are boosting hope for a new generation of more effective weight-loss medicines. ...and more » - G News
Mad Money Lightning Round OT: Cramer Wants To Stay Away From CFN (ARNA, XRTX ... BenzingaMad Money Lightning Round OT: Cramer Wants To Stay Away From CFN (ARNA, XRTX ...BenzingaArena Pharmaceuticals, Inc. (NASDAQ: ARNA) is a good speculative stock, and it has the best profile in fighting obesity, thinks Cramer. ... - G News
Experimental diet pill shows promise, little risk Experimental diet pill shows promise, little riskDanbury News TimesIn the study, Arena Pharmaceuticals' lorcaserin (lore-KASS-ah-rin) caused more people to lose at least 5 percent of their body weight over one year, ...and more » - G News
|